Network Insights Methodology Whitepaper Get Access

AstraZeneca

ORG Health Care / Pharmaceuticals Momentum 7.4ML Momentum Score (0-100). Weighted composite of 9 features: mention velocity, article breadth, relationship density, deal context, recency, market cap, enrichment completeness, mention concentration, entity type. NORMALPSI regime classification. QUIET (<0.3): baseline activity. NORMAL (0.3-0.5): typical deal flow. ELEVATED (0.5-0.7): above-average signals. HIGH (0.7-0.85): significant activity. EXTREME (>0.85): exceptional signal concentration. Primary: Spectral Shift

$81B market cap (Cambridge, UK) manufactures oncology, cardiovascular, respiratory, and rare disease pharmaceuticals. Recent Phase 3 bone disease win and $1.7B CSPC partnership offset $34M Texas kickback settlement.

Phase 3 win in bone disease; $1.7B pact with CSPC; Ultomiris rare disease portfolio expansion; $34M settlement for alleged Medicaid kickbacks
0.58
PSI ScorePlocamium Signal Index - composite z-score from 5 orthogonal signals: news frequency, targeted sentiment, graph centrality, regulatory filings, and clinical trial activity.
7.4
MomentumML Momentum Score (0-100). Weighted composite of 9 features including mention velocity, article breadth, deal context, and relationship density. Retrained weekly.
1%
ConfidenceSignal confidence - percentage of PSI sub-signals with sufficient data (30+ observations). Higher confidence means the PSI score is based on more complete data.
17
ConnectionsDegree centrality - number of unique entities this entity co-occurs with in news signals and articles. Higher = more connected in the intelligence network.
AstraZeneca is graph community structure is reorganizing around this entity — relationship patterns are changing (primary driver: Spectral Shift).
Connected Entities
FDA European Union PlocamiumAI United Kingdom China Eli Lilly Merck Novartis Europe Novo Nordisk Paris Supreme Court Alphabet Yahoo Iran
Watch This Entity
PSI Intelligence
30-Day Trend
2026-06-08 2026-07-08 18 0 Degree Mentions
Signal Decomposition
Attention Cascade
-0.136
Narrative Drift
0.000
Spectral Shift
533.141
Sentiment-Momentum Divergence
0.000
Source Concentration
0.480
Signal
AstraZeneca is graph community structure is reorganizing around this entity — relationship patterns are changing (primary driver: Spectral Shift).
Driver
Ranked #5 of 79 in Health Care — above 95% of sector peers. PSI up 0.28 from yesterday (0.31 -> 0.58).
Action
Baseline conditions. Continue standard monitoring cadence.
Peer Comparison
5 of 79
Sector Rank
+1.90
Peer Z-Score
95%
Sector Percentile
Network Analysis
17 Degree Centrality
Ego Network (top connections)
FDA (weight 32.0)European Union (weight 11.0)PlocamiumAI (weight 11.0)United Kingdom (weight 10.0)China (weight 9.0)Eli Lilly (weight 8.0)Merck (weight 8.0)Novartis (weight 4.0) FDAEuropean UnionPlocamiumAIUnited KingdomChinaEli LillyMerckNovartis AstraZeneca (degree 17) AstraZeneca
Centrality History
2026-06-08 2026-07-08 18 0 Degree Mentions
EntityWeight StatusFirst Seen
FDA 32 NEW
European Union 11 NEW
PlocamiumAI 11 NEW
United Kingdom 10 NEW
China 9 NEW
Eli Lilly 8 NEW
Merck 8 NEW
Novartis 4 NEW
Europe 4 NEW
Novo Nordisk 4 NEW
Paris 3 NEW
Supreme Court 3 NEW
Alphabet 2 NEW
Yahoo 2 NEW
Iran 2 NEW
Florida 2 NEW
Texas 2 NEW
Article Coverage (0)
DateLaneTitle
No Plocamium-authored coverage yet. This entity surfaces in upstream signals (news, filings, trials) but has not yet been a primary subject of a published article. Watch this entity to be alerted when one is published.

Request Access

Full PSI intelligence, network analysis, EDGAR filings, and predicted links require an access token.

Data as of 2026-07-08 ← Intelligence Network